FEBS Letters | |
Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c‐myc by small interfering RNAs | |
Hung, Le1  Kumar, Vijay1  | |
[1] Virology Group, International Centre for Genetic Engineering and Biotechnology, P.O. Box 10504, Aruna Asaf Ali Marg, New Delhi 110067, India | |
关键词: Hepatitis B virus X protein; Transactivation; RNA interference; Hepatocellular carcinoma; Chloramphenicol acetyltransferase assay; CAT; chloramphenicol acetyltransferase; HBx; hepatitis B virus X protein; dsRNA; double-stranded RNA; RNAi; RNA interference; shRNA; small hairpin RNA; siRNA; small interfering RNA; | |
DOI : 10.1016/S0014-5793(04)00113-9 | |
学科分类:生物化学/生物物理 | |
来源: John Wiley & Sons Ltd. | |
【 摘 要 】
With a view to developing therapeutic strategies against hepatocellular carcinoma (HCC), we have recently shown that co-expression of c-myc and the X protein of hepatitis B virus (HBx) resulted in the development of HCC in the X-myc transgenic mice [Lakhtakia et al., J. Gastroenterol. Hepatol. 18 (2003) 80–91]. We now show in cell culture-based studies that small interfering RNA (siRNA) corresponding to HBx and c-myc can regulate expression and transactivation of the target genes. Expression vectors for small hairpin RNAs (shRNAs) against two different regions each of the HBx and c-myc open reading frames were constructed and their regulatory effects were investigated in COS-1 cells. A dose-dependent specific inhibition in the expression levels of HBx and c-myc was observed with individual shRNAs. Further, the recombinantly expressed shRNAs also blocked the transactivation functions of their cognate genes. Though each shRNA worked at a different efficiency, the inhibitory effects with two different shRNAs were cumulative. These results appear promising for developing a siRNA-based therapy for HCC.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912020313904ZK.pdf | 199KB | download |